FFNTF (4Front Ventures) EBITDA Margin %: -19.01% (As of Sep. 2024)


FFNTF 4Front Ventures Corp FFNTF
10 GF Score
Price $0.00
View Full Analysis

What is 4Front Ventures EBITDA Margin %?

4Front Ventures FFNTF -90.00% 10 EBITDA Margin % is -19.01% as of Sep. 2024. GuruFocus rates FFNTF with a GF Score™ of 10/100.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. 4Front Ventures's EBITDA for the three months ended in Sep. 2024 was $-3.26 Mil. 4Front Ventures's Revenue for the three months ended in Sep. 2024 was $17.13 Mil. Therefore, 4Front Ventures's EBITDA margin for the quarter that ended in Sep. 2024 was -19.01%.

4Front Ventures  (OTCPK:FFNTF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

4Front Ventures EBITDA Margin % Related Terms

4Front Ventures EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for 4Front Ventures's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4Front Ventures EBITDA Margin % Chart

4Front Ventures Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -330.49 -35.74 -3.84 6.05 -18.74

4Front Ventures Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -112.46 31.94 -77.50 -11.32 -19.01

FFNTF vs CRYM, PNXP, SKYI: EBITDA Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, 4Front Ventures's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

4Front Ventures EBITDA Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, 4Front Ventures's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where 4Front Ventures's EBITDA Margin % falls into.


FFNTF
10GF Score
4Front Ventures Corp FFNTF
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

4Front Ventures EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

4Front Ventures's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-18.261/97.435
=-18.74 %

4Front Ventures's EBITDA Margin % for the quarter that ended in Sep. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=-3.257/17.132
=-19.01 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -19.01% mean?
4Front Ventures (FFNTF) has a EBITDA Margin % of -19.01% as of Sep. 2024. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on 4Front Ventures and its competitors.
Is 4Front Ventures' EBITDA Margin % too high?
4Front Ventures' current EBITDA Margin % is -19.01%. Overall, 4Front Ventures has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does 4Front Ventures' EBITDA Margin % compare to CRYM and PNXP?
4Front Ventures' EBITDA Margin % of -19.01% can be compared against companies in the Drug Manufacturers industry. The industry median EBITDA Margin % is 12.39. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.39, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on 4Front Ventures and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 4Front Ventures's current EBITDA Margin % is -19.01%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 4Front Ventures stock overvalued right now?
4Front Ventures (FFNTF) has a current EBITDA Margin % of -19.01%. The current EBITDA Margin % is -19.01%. 4Front Ventures' overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For 4Front Ventures (FFNTF), the current EBITDA Margin % is -19.01% as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

4Front Ventures Business Description

Address 7010 E. Chauncey Lane, Suite 235, Phoenix, AZ, USA, 85054
4Front Ventures Corp is a Canadian-based company. It is engaged in the cultivation, processing, extracting, manufacturing, and distribution of cannabis products. It operates in two segments: THC Cannabis and CBD Wellness. The THC Cannabis segment engages in the production and cultivation of THC cannabis, manufacturing and distribution of cannabis products to owned dispensaries and third-party retail customers. The CBD Wellness segment encompasses the production and sale of CBD products to third-party customers.
10GF Score

Get the complete analysis for FFNTF

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price